PTC Therapeutics | PTCT - 贷款资金

股票价格
64.80
每天变化
-5.46 -7.77%
每月一次
-1.28%
每年
30.02%
Q2 预测
66.77


金融业
股票价格
USD
资产
USD 2.9B
现金及等价物
USD 984.65M
销售成本
USD 16.3M
流动资产
USD 2.27B
流动负债
USD 968.43M
债务
USD 2.71B
EBIT
USD -81.62M
EBITDA
USD -70.99M
员工
939
EPS每股收益
USD -1.67
股本和储备
USD -205.31M
销售毛利
USD 148.38M
债务利息支出
USD 50.58M
贷款资金
USD 2.03B
市值
USD 5.38B
净收入
USD -134.97M
营业费用
USD 246.3M
营业利润
USD -81.62M
普通股股本
USD 81.47M
PE价格收益
9.98
税前利润
USD -139.08M
销售收入
USD 164.7M
销售和管理费用
USD 87.2M
股票
USD 79.65M
贸易债权人
USD 45.49M
应收帐款人
USD 181.62M


贷款资金 更改 日
Acadia Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Amgen USD 50B 2.43B 2025-12
BioCryst Pharmaceuticals USD 428.67M 234.31M 2025-12
Biogen USD 6.29B 1.7M 2026-03
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Cytokinetics USD 1.12B 957.23M 2025-12
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Enanta Pharmaceuticals USD 0 0 2024-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Gilead Sciences USD 22.13B 6M 2025-12
Incyte USD 29.41M 785K 2026-03
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 2.03B 193.22M 2025-12
Puma Biotechnology USD 10.87M 222K 2025-06
Roche Holding CHF 27.43B 966M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
TG Therapeutics USD 245.64M 305K 2025-12
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03
Xencor USD 76.48M 11.29M 2025-12